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utilized in 58.1% of cases. Furthermore, a 2 stent strategy was used as the initial
strategy in 40.3% of procedures with final kissing balloon inflation successfully
performed in 74.2%. At 30 days, there was one (1.6%) incidence of TLF, with no other
adverse events. Overall, all cause mortality occurred in 6.5% at follow-up with no MI
or definite/ probable stent thrombosis. Moreover, MACE occurred in 21.0% of patients,
with TVR in 16.1%, TLF in 4.8% and TLR in 4.8%.
Conclusion: The new EES appear to be safe and effective for the treatment of
unprotected left main stem stenosis at median follow-up of 723.5 days. Clearly this
needs to be demonstrated at longer-term follow-up.
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Background: Clinical observations revealed that strut malapposition and Side Branch
(SB) occlusion is common after bifurcations treatment with PCI. Current techniques
for bifurcation stenting often fail to ensure scaffolding of the SB and complete
apposition of stent struts in the bifurcation. Struts floating in the ostium can disturb
blood flow and increase risk of focal restenosis and stent thrombosis, limiting the
success of stent procedures in bifurcations lesions.
Methods: The dedicated Sideguard stent (Cappella Medical Device, Galway, Ireland)
was deployed as SB stent in 2 coronary bifurcation bench models (45° and 70° SB
angle). Commercially available drug eluting stents were used as Main Vessel stents
and malapposition quantified from micro-CT with the Sideguard dedicated SB nitinol
stent (2.5mm and 2.75mm, n=5) was compared with conventional 2-stent stenting
techniques (crush, n=5; culotte, n=3 and t-stenting, n=2).
Results: Rate of malapposed struts within the bifurcation after kissing balloon post-
dilatation using the same balloon sizes and inflation pressure was on average 36.7 ±
8.6 % with conventional techniques, reduced to 16.4 ± 7.5 % with the Sideguard
(p=0008). Area of the SB ostium jailed by stent struts was reduced to 8.3 % when using
the Sideguard compared to an average of 32.8 % after conventional 2-stent techniques
(p=0.0004). Furthermore, the Sideguard device avoid overlap of multiple stent layers,
resulting in less strut malapposition in the Main Vessel proximal to the SB compared
to crush or culotte technique (8.2 % vs. 39.1.%, p=0.0018 and 26.1 %, p=0.024).
Conclusion: Use of the Sideguard as SB stent may offer complete stent scaffolding of
the SB ostium while reducing struts malapposition in the bifurcation ostium and
proximal to the SB compared to conventional 2-stent approaches.
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Background: There is an ongoing controversy regarding the efficacy and safety of
different bifurcation stenting techniques, and dedicated bifurcation stents have been
proposed as a potential alternative. We evaluated healing responses, as assessed with
optical coherence tomography (OCT), and clinical and angiographic outcome, 9
months after percutaneous coronary intervention (PCI) of coronary bifurcation lesions
with the dedicated TRYTON Side-Branch Stent.
Methods: Consecutive patients with coronary bifurcation lesions and significant
involvement of the side-branch underwent PCI with the TRYTON Stent and an
additional XIENCE V stent in a modified culotte technique. Primary endpoint of the
study was the ratio of uncovered to total stent struts at the lesion site, as assessed with
OCT 9 months after PCI. Secondary endpoints were the rate of in-segment restenosis
and late luminal loss at 9 months, as assessed with quantitative coronary angiography
(QCA). Clinical endpoints included the rate of target lesion revascularization (TLR),
target vessel revascularization (TVR), myocardial infarction (MI), cardiac death, and
stent thrombosis at 1 year.
Results: Between January and June 2010, 20 patients (mean age 68±10y, 65% male,
25% diabetes, 95% LAD/Diagonal) were included. Implantation of the TRYTON stent
was successful in 18 (90%). Failures were due to inability to cross the bifurcation with
TRYTON in 1, TRYTON dislodgment during removal of jailed wire in the other.
Angiographic follow-up was available in 18 (90%) at 9.7±1 months. OCT was
performed in 15 (75%, two additional patients with severe restenosis precluding OCT,
1 without TRYTON stent). At 1 year, 6 patients had undergone TVR (30%), of which
4 were TLR (20%). Three of these restenoses were silent. Four occurred at the proximal
main branch stent edge. Five patients suffered MI (25%), 4 of which were
periprocedural and without clinical consequences. There were no deaths nor stent
thromboses.
Conclusion: In patients with complex bifurcation anatomy, a TLR rate of 20% was
seen after implantation of the dedicated first generation TRYTON Side-Branch Stent
in combination with XIENCE V stents. OCT and QCA may help to understand healing
responses and failures. Nine months’ OCT and angiographic follow-up will be
presented.
TCT-312
Effect and mechanisms of coronary bifurcation angle from 3-D on clinical
outcomes after percutaneous treatment with stents-results from DKCRUSH-II
trial
Shao-Liang Chen1, Teguh Santoso2, Ya-Wei Xu3, Qiang Fu4, Chitprapai Paiboon5,
Yong Yong Zhou6, Shi-Qing Ding7, Tak W Kwan8
1Nanjing First Hospital, Nanjing Medical University, Nanjing, China; 2Medistra
Hospital, University of Indonesia Medical School, Jakarad, Indonesia; 3Shanghai
10th People’s Hospital, Shanghai, China; 4Xuzhou Central Hospital, Xuzhou, China;
5Bangkok General Hospital, Bangkok, Thailand; 6Zhangjiagang People’s Hospital,
Zhangjiagang, China; 7Huainan Xinhua Hospital, Huainan, China; 8Beth Israel
Hospital, NY, NY
Background: The role of bifurcation angle (BA) in predicting clinical outcomes after
stenting bifurcation lesions remains to be unclear. The aim of the present study was to
investigator the dynamic change of BA and its predictive value for patients with
coronary bifurcation lesions treated by stents.
Methods: 347 patients were completely studied from our DKCRUSH-II study. BA
was calculated by 3-D quantitative coronary analysis. Primary endpoint was the
occurrence of composite major adverse cardiac events(MACE) at 12-month, including
cardiac death, myocardial infarction(MI) and target vessel revascularization(TVR).
End point was the rate of binary restenosis and stent thrombosis at the end of clinical
follow-up.
Results: Stenting was associated with increase of proximal BA(153.660±21.490) and
the reduction of distal BA. The cut-off value of distal BA for predicting MACE was
600. Distal BA in <600 group had slight reduction after stenting(-1.96±13.580 vs. -
12.12±23.580, p<0.001); two-stent technique was associated with significant reduction
of distal BA (-4.05±14.200),compared to PS group[1.55±11.73,p=0.003); the TLR,
TVR and MACE rate was 16.5%,19.0% and 21.5% in one-stent group (n=79),
compared to 3.8% (p=0.002),7.5%(p=0.016) and 9.8%(p=0.024) in two-stent group
(n=133), respectively; further, the rate of TLR, TVR and MACE in DK group (n=108)
was 2.8%, 6.5%, and 8.3%, compared to 14.4%, 17.3%, and 20.2% in PS group
(p=0.003, =0.019, and =0.017). Among patients in≥600 group, there were no
differences in distal BA, ST, MI, MACE, death, TLR, TVR between one-vs. two-stent
groups; after stenting procedure, there was only slight change of distal BA in LAD-
LCX subgroup (from 88.540±21.330 at baseline to 82.440±31.720 post-stenting),
compared to either LAD-D, or LCX-OM,or RCAd (all p<0.001).
Conclusion: Complex stenting was associated with significant reduction of distal BA.
Two-stent, as DK crush stenting, had reduced rate of MACE in patients in <600 group,
compared to one-stent technique.
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Background: Simple crossover stenting in non-left main (LM) bifurcation lesion
without opening of stent strut in the ostium of side branch demonstrated a favorable
outcome. However the safety and efficacy of the same strategy for LM crossover
stenting has not been validated yet.
Methods: Among the patients who successfully underwent LM to LAD crossover
stenting due to LM or ostial left anterior descending coronary artery (LAD) disease,
the clinical outcomes of the patients with non-significant residual stenosis (<70%) in
ostial LCX after stenting were evaluated. The 3-year outcome analyzed by the
composite of cardiac death,, myocardial infarction, repeat revascularization, and stent
thrombosis.
Results: Among the included 106 patients, 88 (83%) patients were deferred without
any additional procedure in ostial LCX. Preinterventional and post-stent % diameter
stenosis (DS) of ostial LCX were 23±14% and 33±16%, respectively (p<0.001). The
rate of MACE was 11.4 % (cardiac death 4.5%, myocardial infarction 2.27%, repeat
revascularization 9.1%, and stent thrombosis 2.27%, respectively). Purely ostial LCX
related MACE was 20%. Event free survival curve was obtained (see the attached
figure).
B85JACC Vol 58/20/Suppl B  |  November 7-11, 2011  |  TCT Abstracts/POSTER/Left Main and Bifurcation Stenting
P
O
S
T
E
R
S
www.JACC.TCTAbstracts2011
